Envomed

Company Overview

Snapshot

Founded in September 1999, Envomed operates with 1–10 employees, focusing on innovative solutions for medical waste. In February 2024, the company secured a grant from Takeda, highlighting its strategic importance in the healthcare and industrial technology sectors.

Business overview

Envomed develops an on-site medical waste treatment system designed for healthcare facilities. This technology neutralizes pathogens and reduces waste volume, converting hazardous medical waste into non-hazardous material for safe disposal. By eliminating the need for incineration or external treatment, Envomed's solution aims to reduce environmental impact and lower waste management costs for healthcare providers, operating within the Industrial Technologies sector and serving the healthcare industry.

Strategic signal

In November 2023, Envomed's technology for treating medical waste on-site was highlighted as a 'game-changer' by Haaretz. This recognition underscores the company's innovative approach to addressing critical environmental and health risks associated with medical waste disposal, signaling strong market validation and potential for broader adoption within the healthcare sector.

Company Intelligence Q&A

What is Envomed's core offering?

Envomed provides an on-site medical waste treatment system that processes waste directly within healthcare facilities, neutralizing pathogens and reducing waste volume to transform hazardous medical waste into non-hazardous material.

When was Envomed founded?

Envomed was founded in September 1999.

What was a key media recognition for Envomed in late 2023?

In November 2023, Haaretz highlighted Envomed's technology for treating medical waste on-site as 'game-changing'.

Which markets does Envomed currently serve?

Envomed currently serves geomarkets including Asia, Europe, and Israel.